MARIOTTI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 404.594
NA - Nord America 23.365
AS - Asia 10.637
SA - Sud America 1.563
AF - Africa 253
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 26
Totale 440.469
Nazione #
IT - Italia 394.228
US - Stati Uniti d'America 22.989
CN - Cina 3.977
SG - Singapore 3.952
NL - Olanda 2.961
UA - Ucraina 2.085
SE - Svezia 1.203
BR - Brasile 1.200
FR - Francia 940
VN - Vietnam 862
GB - Regno Unito 788
FI - Finlandia 778
DE - Germania 771
HK - Hong Kong 394
IN - India 313
KR - Corea 242
CA - Canada 204
PL - Polonia 126
TR - Turchia 118
BD - Bangladesh 115
AR - Argentina 109
IQ - Iraq 107
MX - Messico 105
RU - Federazione Russa 99
EC - Ecuador 79
ES - Italia 73
BE - Belgio 72
ID - Indonesia 69
JP - Giappone 65
CH - Svizzera 57
RO - Romania 55
PK - Pakistan 53
ZA - Sudafrica 52
AL - Albania 51
SA - Arabia Saudita 45
MA - Marocco 43
CO - Colombia 41
SM - San Marino 39
PH - Filippine 38
JO - Giordania 37
IR - Iran 34
AT - Austria 32
VE - Venezuela 31
EG - Egitto 30
CL - Cile 29
IE - Irlanda 29
KE - Kenya 28
IL - Israele 26
PY - Paraguay 26
UZ - Uzbekistan 26
NO - Norvegia 23
PT - Portogallo 23
AU - Australia 22
EU - Europa 22
GR - Grecia 21
TN - Tunisia 21
MU - Mauritius 19
MY - Malesia 19
PE - Perù 19
LT - Lituania 18
TH - Thailandia 17
UY - Uruguay 17
HU - Ungheria 16
RS - Serbia 16
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
DZ - Algeria 14
AZ - Azerbaigian 13
KZ - Kazakistan 12
NP - Nepal 12
OM - Oman 12
BG - Bulgaria 11
CR - Costa Rica 10
PS - Palestinian Territory 10
BO - Bolivia 9
DK - Danimarca 9
JM - Giamaica 9
PA - Panama 9
BA - Bosnia-Erzegovina 8
BY - Bielorussia 8
ET - Etiopia 8
KG - Kirghizistan 8
NG - Nigeria 8
TW - Taiwan 8
GE - Georgia 7
MD - Moldavia 7
DO - Repubblica Dominicana 6
LB - Libano 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
HR - Croazia 5
MK - Macedonia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AO - Angola 4
BB - Barbados 4
EE - Estonia 4
GT - Guatemala 4
HN - Honduras 4
Totale 440.388
Città #
Cagliari 354.786
Uta 5.991
Rome 3.414
Milan 2.200
Fairfield 2.039
Singapore 1.932
Woodbridge 1.898
Amsterdam 1.893
Ashburn 1.802
Chandler 1.649
Houston 1.338
Boardman 1.170
Dallas 1.114
Ann Arbor 1.064
Jacksonville 989
Wilmington 977
San Jose 868
Naples 819
Nyköping 780
Seattle 751
Beijing 700
Cambridge 672
Bologna 595
Florence 569
Helsinki 502
Los Angeles 484
Dearborn 436
Bari 384
Catania 379
Nanjing 374
Turin 365
Palermo 363
Hong Kong 361
Hefei 343
Lauterbourg 324
Boston 308
Ho Chi Minh City 292
The Dalles 292
Buffalo 260
Seoul 234
New York 227
Santa Clara 223
Verona 217
Shanghai 212
Padova 203
Hanoi 196
Genoa 190
Pescara 124
Shenyang 124
Toronto 123
Guangzhou 116
San Diego 116
Hebei 113
Parma 112
Brescia 110
Venice 106
Pisa 104
Jiaxing 103
Mountain View 103
Nanchang 103
Sassari 97
Reggio Emilia 96
Modena 95
São Paulo 95
Messina 92
Redwood City 88
Livorno 84
Munich 83
Tianjin 80
Atlanta 77
Taranto 77
Hangzhou 76
Changsha 75
Salerno 74
London 73
Monza 73
Perugia 73
Vicenza 73
Frankfurt am Main 69
Bergamo 68
Napoli 66
Torino 65
Chicago 64
Orem 63
Zhengzhou 61
Lucca 60
Council Bluffs 59
Orange 55
Trieste 55
San Mateo 54
Rimini 53
Tokyo 50
Jinan 49
Dong Ket 48
Brussels 47
Ningbo 46
Norwalk 46
Reggio Calabria 46
Treviso 46
Falls Church 45
Totale 401.332
Nome #
Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA–PTH assay 34.688
Dosaggio della tireoglobulina nell’aspirato dei linfonodi del comparto centrale per l’identificazione intraoperatoria delle metastasi da carcinoma differenziato della tiroide. 14.494
Ricerca di galectina-3, HBME-1 e grading delle atipie nell’agoaspirato dei noduli tiroidei con citologia indeterminata: risultati preliminari. 10.876
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 4.975
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.875
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.764
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view 4.045
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe 3.878
Dosaggio della tireoglobulina (TG) negli agoaspirati linfonodali in pazienti con anticorpi anti-Tg (TgAb) circolanti. 3.875
Hurthle tumors: a class of thyroid malignancy with massive chromosome disturbance 3.839
Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study 3.811
Subclinical ocular alterations in thyroid eye disease. An additional score to predict the progression of disease 3.530
Subclinical alterations of extraocular muscles in Graves' Disease 3.513
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.411
Cortical adrenal mitochondrial morphology changes in functional state: new insights 3.293
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.253
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.190
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.166
Assessing RET gene breakage in thyroid fine needle aspiration by fish: advantages and limits 3.095
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 3.001
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.977
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.976
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 2.964
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.941
Differentiated thyroid cancer: indications and extent of central neck dissection--our experience. 2.935
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.933
null 2.930
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.885
RET/PTC rearrangements in hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.813
Intertriginous and seborrheic dermatitis-like lesions in an endocrine patient 2.798
Predictive factors of malignancy in follicular thyroid nodules (THY3): Our experience on 324 patients 2.775
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.700
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.683
Primary thyroid leiomyosarcoma: a case report and review of the literature 2.663
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.655
Utilità della scintigrafia con 99MTC-SestaMIBI nella diagnosi e nella gestione della tireotossicosi indotta da amiodarone. 2.652
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.636
Diagnosi differenziale del nodulo tiroideo: la calcemia non è mai utile? 2.574
Thyroid autoimmunity and thyroid cancer: pathological and molecular study in a longitudinal series of unselected nodules. 2.522
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.490
Amiodarone-induced thyrotoxicosis. A review 2.485
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.470
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.448
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.437
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.391
High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients. 2.387
Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis 2.385
Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules 2.336
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.330
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.325
RET/PTC rearragements in Hashimoto’s thyroiditis nodules. 2.318
Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis 2.304
RET/PTC rearrangement in Hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.299
Autoimmunita’ tiroidea e carcinoma della tiroide: studio prospettico citologico, molecolare e istologico. 2.298
RET/PTC rearrangements in Hashimoto’s thyroiditis nodules 2.298
Fifteen-year follow-up of thyroid function in lithium patients 2.297
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.238
A genetic epidemiology study of congenital adrenal hyperplasia in Italy 2.231
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.218
Riarrangiamenti RET/PTC in noduli insorti in tiroidite d’Hashimoto 2.204
RET/PTC rearrangements in unselected nodules from patients with Hashimoto’s thyroiditis 2.202
The birth and rise of a craniopharyngioma: the radiological evolution of an incidental craniopharyngioma detected on serial MRI during medical treatment of a macroprolactinoma 2.171
3-D structure of mitochondrial cristae in rat adrenal cortex varies after acute stimulation with ACTH and CRH 2.148
The diagnostic value of parathyroid assay in wash-out fluid from fine needle aspiration biopsy of neck masses in primary hyperparathyroid patients with uncertain 99mTC-SESTAMIBI scintigraphy. 2.124
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.124
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.121
Risultati preliminari di uno studio longitudinale in pazienti affetti da morbo di Basedow con alterazioni subcliniche dei muscoli oculari. 2.092
Area di intensa iodocaptazione al WBS con 131I simulante metastasi polmonare causata da angioma capillare a basso flusso. 2.066
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 2.044
I noduli tiroidei e le tireopatie autoimmuni interferiscono con la scintigrafia sesta-MIBI e con l’ecografia nella localizzazione delle paratiroidi nell’iperparatiroidismo primitivo. 2.043
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 2.015
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.990
Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism: is it really mandatory? 1.958
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.957
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.949
Prevalence of overweight and obesity in Sardinian adolescents 1.940
High prevalence of autoimmune thyroid disease in thyroids with oncocytic tumors. 1.881
High prevalence of subclinical extraocular muscles alterations in graves’ disease patients asymptomatic for active graves’orbitopathy 1.806
99mTc-Sestaminbi scan is not useful in the pre-surgical evaluation of thyroid nodules with oncocytic cytology. 1.773
Asociation beween thyroid autoimmunità and papillary thyroid carcinoma: recent confirmation form a prospective study. 1.765
Brain perfusion abnormalities showed by 99mTc-ECD SPECT in patients with autoimmune thyroid disorders 1.762
Fibrinogen and D-dimer levels in autoimmune subclinical and overt hypothyroidism and effects of levothyroxine treatment. 1.746
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.744
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.734
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association? 1.725
null 1.717
Elevata prevalenza di alterazioni subcliniche dei muscoli extraoculari in pazienti con morbo di Basedow asintomatici per oftalmopatia attiva. 1.703
Utilità dell’ecocolor Doppler nella diagnosi differenziale tra gozzo multinodulare tossico e variante multinodulare del morbo di Basedow. 1.691
99mTc-SESTAMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. 1.639
The usefulness of calcitonin assay in fine needle aspiration biopsy (FNAB) fluid of neck masses of patients with primitive and metastatic medullary thyroid carcinoma (MTC). 1.634
Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function 1.621
Ricerca della mutazione BRAFV600E e del riarrangiamento RET/PTC negli agoaspirati tiroidei in pazienti sardi 1.603
99mTc-Sesta-MIBI thyroid scan in the differential diagnosis of amiodarone-induced thyrotoxicosis. 1.599
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica dei noduli tiroidei 1.595
99mTc-SestaMIBI scintigraphy of thyroid gland in patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma 1.590
Classification and Etiopathogenesis of Hypothyroidism 1.568
Galectina-3 e HBME-1 nell’agoaspirato dei noduli a citologia indeterminata: confronto con I parametri eco-color-doppler. 1.521
Coexistent thyroid pathology may impair parathyroid localization in primary hyperparathyroidism: usefulness of PTH assay in FNAB fluid wash-out. 1.520
Functional characterization of aCDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 1.508
null 1.503
Totale 298.665
Categoria #
all - tutte 570.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 570.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112.772 0 0 0 0 0 0 0 0 0 5.009 4.442 3.321
2021/202219.562 2.304 1.740 1.176 1.523 1.735 1.501 1.284 1.005 1.499 1.617 2.159 2.019
2022/202329.516 2.309 3.062 2.893 2.252 2.329 2.553 1.637 3.186 2.457 2.086 2.856 1.896
2023/202438.480 2.403 1.706 1.867 2.709 3.353 4.983 5.325 3.254 2.226 3.004 3.828 3.822
2024/202582.925 25.696 15.667 18.561 5.774 3.266 3.486 4.543 1.051 1.459 1.105 1.179 1.138
2025/202621.059 1.600 965 2.757 1.832 1.460 1.855 3.107 2.109 3.805 1.569 0 0
Totale 441.355